|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.7 TWD | +1.41% |
|
+1.06% | -0.52% |
Excelsior Biopharma Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was TWD 190.11 million compared to TWD 187.98 million a year ago. Net loss was TWD 33.68 million compared to TWD 23.91 million a year ago.
Basic loss per share from continuing operations was TWD 0.73 compared to TWD 0.52 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -0.52% | 41.45M | |
| +40.73% | 739B | |
| +31.43% | 598B | |
| -6.30% | 353B | |
| +15.15% | 318B | |
| +4.05% | 285B | |
| +14.77% | 240B | |
| +9.23% | 210B | |
| -5.15% | 206B | |
| +6.17% | 164B |
EXCELSIOR BIOPHARMA INC. 
